logo

Vertex Pharmaceuticals Inc. (VRTX)



Trade VRTX now with
  Date
  Headline
5/15/2019 8:35:59 AM Vertex And Kymera Therapeutics Establish Strategic Collaboration To Develop Targeted Protein Degradation Medicines
4/30/2019 8:38:46 AM Vertex Pharma: FDA Approves KALYDECO
4/2/2019 8:10:20 AM Vertex Appoints Charles Wagner As EVP And CFO
3/26/2019 7:38:41 AM William Blair Lifts Vertex Pharmaceuticals Inc. (VRTX) To Outperform From Market Perform
3/6/2019 8:20:18 AM VRTX : Tezacaftor And Ivacaftor Meets Primary Endpoint Of Improvement In Lung Function In People With Cystic Fibrosis
2/14/2019 9:09:28 AM Vertex Reports Positive Phase 3 Study For Tezacaftor/Ivacaftor Combination In Children Aged 6-11 Years With CF
2/5/2019 4:05:57 PM Vertex Pharma Q4 EPS $5.97 Vs. $0.39 Year Ago
1/28/2019 9:22:14 AM Vertex: Health Canada Grants Market Authorization For KALYDECO In Children With Certain Mutations In CFTR Gene
1/23/2019 4:06:07 PM Vertex Says Ian Smith Terminated As COO And Interim CFO
1/21/2019 4:02:26 AM Vertex:EC Oks ORKAMBI For Treatment Of Children With Cystic Fibrosis Aged 2 -5 Yrs Old With Most Common Form Of Disease
1/4/2019 8:16:21 AM X-Chem Announce Expansion Of Its Collaboration With Vertex
1/4/2019 7:01:24 AM CRISPR Therapeutics, Vertex Announce FDA Fast Track Designation For CTX001 For Treatment Of Sickle Cell Disease